Support for LAist comes from
Audience-funded nonprofit news
Stay Connected
Audience-funded nonprofit news
Listen

Share This

News

LA Sues Company In Beverly Hills For Selling An Unapproved Coronavirus Test

This scanning electron microscope image shows SARS-CoV-2 (round gold objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. (NIAID-RML)
()

With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support today. 

Los Angeles prosecutors are suing a company with offices in Beverly Hills for selling an at-home COVID-19 blood test that has not been approved by the Food and Drug Administration.

The L.A. City Attorney and L.A. County District Attorney announced the suit against the Applied BioSciences Corporation, its president, Chris Bridges, and founder Scott Stevens. The company claims it is "focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases," according to a statement from the city and county.

District Attorney Jackie Lacey says that fraudulent medical tests are a public health risk because they can give consumers a false sense of security that they aren't sick.

"People who believe they are healthy or virus-free are more likely to return to work and otherwise move about freely, increasing the risk to themselves and others."

Lacey says the FDA has approved the first at-home nasal swab collection kit for COVID-19 testing, but Applied BioSciences was selling a blood antibody test that has
Support for LAist comes from
not been approved.

Prosecutors say the company claimed in advertisements its tests could diagnose COVID-19 from a single finger prick of blood — and could do it with 96.3% accuracy in 15 minutes. The company allegedly marketed and sold the test kits on its website for $35 each.

The lawsuit aims to stop the company from marketing or selling the kits and seeks restitution for consumers who bought them.

Last month, city attorney Mike Feuer announced similar actions taken against businesses selling unapproved at-home kits. This lawsuit is the latest in a crackdown on coronavirus-related fraud with officials targetting companies for price gouging and making false and misleading claims.

Our news is free on LAist. To make sure you get our coverage: Sign up for our daily coronavirus newsletter. To support our non-profit public service journalism: Donate Now.

At LAist, we believe in journalism without censorship and the right of a free press to speak truth to those in power. Our hard-hitting watchdog reporting on local government, climate, and the ongoing housing and homelessness crisis is trustworthy, independent and freely accessible to everyone thanks to the support of readers like you.

But the game has changed: Congress voted to eliminate funding for public media across the country. Here at LAist that means a loss of $1.7 million in our budget every year. We want to assure you that despite growing threats to free press and free speech, LAist will remain a voice you know and trust. Speaking frankly, the amount of reader support we receive will help determine how strong of a newsroom we are going forward to cover the important news in our community.

We’re asking you to stand up for independent reporting that will not be silenced. With more individuals like you supporting this public service, we can continue to provide essential coverage for Southern Californians that you can’t find anywhere else. Become a monthly member today to help sustain this mission.

Thank you for your generous support and belief in the value of independent news.

Chip in now to fund your local journalism
A row of graphics payment types: Visa, MasterCard, Apple Pay and PayPal, and  below a lock with Secure Payment text to the right
(
LAist
)

Trending on LAist